Claudia G Bica
Overview
Explore the profile of Claudia G Bica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito Suffert S, Motke B, Linhares A, Vargens A, Alano T, Lutz A, et al.
Am J Hosp Palliat Care
. 2022 Dec;
40(10):1098-1105.
PMID: 36564870
An estimated 9.6 million people died from cancer globally in 2018, which is a reflection of the quality of patients' end-of-life care and its costs. To estimate direct medical costs...
2.
Silva T, Jung I, Trott A, Bica C, Casarin J, Fortuna P, et al.
Am J Hum Biol
. 2017 May;
29(5).
PMID: 28488759
Objective: Serotonin (5-HT) is a pleiotropic molecule that exerts several functions on brain and peripheral tissues via different receptors. The gene for the 5-HT2A receptor shows some variations, including a...
3.
Ranzi A, da Silva J, Graziottin T, Annels N, Bica C
Appl Immunohistochem Mol Morphol
. 2015 Nov;
25(3):178-183.
PMID: 26574637
Bladder cancer (BCa) is the most frequent urinary tract neoplasm. BCa results in significant mortality when the disease presents as muscle invasive. Around 75% to 80% of patients present with...
4.
Schwingel T, Klein C, Nicoletti N, Dora C, Hadrich G, Bica C, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2014 Jun;
387(9):837-48.
PMID: 24908156
Oxaliplatin (OXA) is a platinum compound widely used in the treatment of some solid tumors, especially colorectal cancer. Despite its usefulness, oxaliplatin-associated neurotoxicity represents the main dose-limiting factor of this...